arrow
B

Bianca Altvater

military hospital ulm
H指数:27
被引数:2,068

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ganglioside SSEA-4 in Ewing sarcoma marks a tumor cell population with aggressive features and is a potential cell-surface immune target
2024-05-241
OAAI
Preclinical development of CAR T cells with antigen-inducible IL-18 enforcement to treat GD2-positive solid cancers
2024-03-220
PRE
CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process

CAR T细胞作为抗实体癌的微药物: 在一步工程过程中将效应T细胞介导的细胞死亡与血管靶向相结合

2023-06-305
OAAI
CAR T cells as micropharmacies to induce locoregional tumor vascular infarction by antigen-specific delivery of tissue factor to the tumor microenvironment

Car-t细胞作为微药物通过抗原特异性递送组织因子到肿瘤微环境诱导局部区域肿瘤血管梗塞

2023-04-040
PRE
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse

使用基质锚定细胞因子增强ADCC: F16IL2和BI 836858移植后AML复发的1期试验

2022-06-228
OAAI
GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18

符合GMP标准的卡车制造: 靶向GD2并释放可诱导IL-18的CAR T细胞

2022-03-2436
OAAI
Requirement for YAP1 signaling in myxoid liposarcoma
2019-07-010
PRE
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
2019-05-0184
OAAI
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma

Phosphatidylinositol-3-kinase (PI3K)/Akt信号在粘液样脂肪肉瘤中功能上至关重要

2019-04-0131
OAAI
Requirement for YAP1 signaling in myxoid liposarcoma
2019-03-2124
OAAI
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma

FUS-DDIT3融合蛋白驱动的igf-ir信号是粘液样脂肪肉瘤的治疗靶点

2017-10-1241
OAAI
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G

用活化和GD2-specific的嵌合抗原受体工程改造的人NK细胞靶向尤因肉瘤诱导免疫抑制性hla-g上调

2016-10-28101
OAAI